Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Serin

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Bulletin Du Cancer|August 22, 2022
[Cancers induced by occupational exposure: What progress has been made?]Benoit Delabrusse, Brigitte Le Meur, Léa Vazquez, et al.
Bulletin Du Cancer|March 13, 2002
[Cancer networks]Fadila Farsi, Pierre Bey, Daniel Serin, et al.
BMC Health Services Research|June 23, 2012
Development and feasibility of a set of quality indicators relative to the timeliness and organisation of care for new breast cancer patients undergoing surgeryMarie Ferrua, Mélanie Couralet, Gérard Nitenberg, et al.
Bulletin Du Cancer|October 6, 2005
[Parcours de femmes 2001, a French survey on the management and needs of women with breast and gynecological cancer: what's new after 8 years?]Daniel Serin, Jean-Marie Dilhuydy, Nicole Guiochet, et al.
Annals of Surgical Oncology|May 8, 2003
Randomized multicentric study of perioperative chemotherapy with mitoxantrone in early breast cancerThierry Petit, Christian Borel, Serge Theobald, et al.
Bulletin Du Cancer|September 21, 2015
[Methods of development of recommendations for clinical practice (RCP) and of setting-up of a platform cancer heart vessels (PTF-CHV) in the inter3C Vaucluse-Arles]Philippe Debourdeau, Catherine Meuleman, Ghislaine Dufaitre, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2006
Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized studyAlain Toledano, Pascal Garaud, Daniel Serin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trialAlain Toledano, David Azria, Pascal Garaud, et al.
Bulletin Du Cancer|April 5, 2016
["SOS SEIN 84" accelerated breast disease management: Patients satisfaction survey]Antoine Arnaud, Magali Dumuids, Alice Mège, et al.
Breast (Edinburgh, Scotland)|October 19, 2006
Gemcitabine and epirubicin in patients with metastatic breast cancer: a phase I/II studyMario Campone, Pierre Fumoleau, Patrice Viens, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Bulletin Du Cancer|August 22, 2022
[Cancers induced by occupational exposure: What progress has been made?]Benoit Delabrusse, Brigitte Le Meur, Léa Vazquez, et al.
Bulletin Du Cancer|March 13, 2002
[Cancer networks]Fadila Farsi, Pierre Bey, Daniel Serin, et al.
BMC Health Services Research|June 23, 2012
Development and feasibility of a set of quality indicators relative to the timeliness and organisation of care for new breast cancer patients undergoing surgeryMarie Ferrua, Mélanie Couralet, Gérard Nitenberg, et al.
Bulletin Du Cancer|October 6, 2005
[Parcours de femmes 2001, a French survey on the management and needs of women with breast and gynecological cancer: what's new after 8 years?]Daniel Serin, Jean-Marie Dilhuydy, Nicole Guiochet, et al.
Annals of Surgical Oncology|May 8, 2003
Randomized multicentric study of perioperative chemotherapy with mitoxantrone in early breast cancerThierry Petit, Christian Borel, Serge Theobald, et al.
Bulletin Du Cancer|September 21, 2015
[Methods of development of recommendations for clinical practice (RCP) and of setting-up of a platform cancer heart vessels (PTF-CHV) in the inter3C Vaucluse-Arles]Philippe Debourdeau, Catherine Meuleman, Ghislaine Dufaitre, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2006
Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized studyAlain Toledano, Pascal Garaud, Daniel Serin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trialAlain Toledano, David Azria, Pascal Garaud, et al.
Bulletin Du Cancer|April 5, 2016
["SOS SEIN 84" accelerated breast disease management: Patients satisfaction survey]Antoine Arnaud, Magali Dumuids, Alice Mège, et al.
Breast (Edinburgh, Scotland)|October 19, 2006
Gemcitabine and epirubicin in patients with metastatic breast cancer: a phase I/II studyMario Campone, Pierre Fumoleau, Patrice Viens, et al.
Pageof 4